ArticleFrontiers in immunology2023

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients.

Hualin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.